Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+146.0%
5Y CAGR+50.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+146.0%/yr
vs +2.8%/yr prior
5Y CAGR
+50.8%/yr
Recent acceleration
Acceleration
+143.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.8x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 837.19% |
| 2024 | -113.93% |
| 2023 | -14.35% |
| 2022 | 56.23% |
| 2021 | -18.75% |
| 2020 | 107.32% |
| 2019 | 23.54% |
| 2018 | 50.34% |
| 2017 | 257.87% |
| 2016 | 164.61% |